Full Text
PCV20 COST EFFECTIVENESS OF ANTIHYPERTENSIVE MONO-THERAPYWITH PERINDOPRIL OR ENALAPRIL IN ELDERLY PATIENTS FROM THE THIRD PARTY PAYER PERSPECTIVE

Abstract

Authors

T Hermanowski R Jaworski M Czech R Pachocki

Back to Volume 7, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×